Example: Heart Attack
Clinical Trials Sponsored by Par Pharmaceutical, Inc.
Total 36 results
-
NCT03297502CompletedConditions: Atopic Dermatitis
-
NCT01380522CompletedConditions: To Determine the Bioequivalence Study Under Fed
-
NCT01380509CompletedConditions: To Determine the Bioequivalence Study Under Fasting
-
NCT01380431CompletedConditions: To Determine Bioequivalence Under Fed Conditions
-
NCT01375244CompletedConditions: Healthy
-
NCT01994642TerminatedConditions: Otitis Media in Patients With Tympanostomy Tubes
-
NCT01910155TerminatedConditions: Otitis Externa
-
NCT01380496CompletedConditions: To Determine Bioequivalence Under Fed Conditions
-
NCT01380483CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT01380457CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00659685CompletedConditions: Healthy
-
NCT00659074CompletedConditions: Healthy
-
NCT00654277CompletedConditions: Healthy
-
NCT00653458CompletedConditions: Healthy
-
NCT00653419CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00652730CompletedConditions: To Determine Bioequivalence Under Fed Conditions
-
NCT00653393CompletedConditions: To Determine the Bioavailability of Tranylcypromine
-
NCT00653003CompletedConditions: To Determine Bioequivalence Under Fed Conditions
-
NCT00652665CompletedConditions: To Determine the Bioequivalence Study Under Fasting
-
NCT00654043CompletedConditions: Healthy
-
NCT00653549CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00653380CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00653315CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00653120CompletedConditions: To Determine Bioequivalence Under Fasting Conditions
-
NCT00653055CompletedConditions: To Determine Bioequivalence Under Fasting Conditions